Clinical Trial Update: Prevention of Breakthrough CINV in Patients Receiving Moderately or Highly Emetogenic Chemotherapy [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial update focused on preventing breakthrough chemotherapy-induced nausea and vomiting in patients receiving moderately or highly emetogeni…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chemotherapy-induced Nausea and Vomiting

Snippet

Sponsor: Simon Williamson Clinic | Conditions: Chemotherapy Induced Nausea and Vomiting | Phase 2 | Status: UNKNOWN